CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-01 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −272 | 4,354 | ||
| 2024-05-31 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +273 | $79.02 | $22K | 7,780 |
| 2024-05-31 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −273 | $136.55 | $37K | 7,507 |
| 2024-05-31 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −273 | 4,626 | ||
| 2024-05-29 | SHERWIN STEPHEN A Director | Option exercise 10b5-1 | +25,000 | $42.76 | $1.1M | 51,504 |
| 2024-05-29 | SHERWIN STEPHEN A Director | Sale 10b5-1 | −25,000 | $133.46 | $3.3M | 26,504 |
| 2024-05-29 | SHERWIN STEPHEN A Director | Option exercise 10b5-1 | +15,000 | $47.89 | $718K | 41,504 |
| 2024-05-29 | SHERWIN STEPHEN A Director | Sale 10b5-1 | −15,000 | $133.47 | $2.0M | 26,504 |
| 2024-05-29 | SHERWIN STEPHEN A Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −25,000 | 0 | ||
| 2024-05-29 | SHERWIN STEPHEN A Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −15,000 | 0 | ||
| 2024-05-22 | RASTETTER WILLIAM H Director | Grant or award · Restricted Stock Unit | +2,869 | 2,869 | ||
| 2024-05-22 | POON CHRISTINE A Director | Grant or award · Restricted Stock Unit | +1,435 | 1,435 | ||
| 2024-05-22 | POON CHRISTINE A Director | Grant or award · Non-Qualified Stock Option | +2,982 | 2,982 | ||
| 2024-05-22 | Sharp Shalini Director | Grant or award · Restricted Stock Unit | +1,435 | 1,435 | ||
| 2024-05-22 | Sharp Shalini Director | Grant or award · Non-Qualified Stock Option | +2,982 | 2,982 | ||
| 2024-05-22 | SHERWIN STEPHEN A Director | Grant or award · Restricted Stock Unit | +2,869 | 2,869 | ||
| 2024-05-22 | POPS RICHARD F Director | Grant or award · Restricted Stock Unit | +2,869 | 2,869 | ||
| 2024-05-22 | MORROW GEORGE J Director | Grant or award · Restricted Stock Unit | +2,869 | 2,869 | ||
| 2024-05-22 | LYONS GARY A Director | Grant or award · Restricted Stock Unit | +1,435 | 1,435 | ||
| 2024-05-22 | LYONS GARY A Director | Grant or award · Non-Qualified Stock Option | +2,982 | 2,982 |
Page 31 of 49 · 963 trades